Bone Growth Stimulators Market by Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, and Platelet-Rich Plasma), Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, and Others), and Distribution Channel (Hospitals & Clinics, Home Care, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
- ALL3848213
- 238 Pages
- March 2020
- Healthcare
Bone growth stimulators are used for bone growth, which also aid in broken bone healing process. Bone growth stimulators help in production of new bone cells and work in case of all fractures. In addition, it is used for healing of long leg bones such as tibia and in surgical procedures such as spinal fusions, which are difficult to heal. Bone growth stimulators include bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma.
Rise in number of trauma and accident cases, increase in prevalence of arthritis, surge in inclination of patients toward minimally invasive & non-invasive surgical treatments, rise in geriatric population, and rapid demand and adoption of platelet-rich plasma and bone morphogenetic proteins are some factors that fuel the growth of the bone growth stimulators market. In addition, rise in cases of diabetes and other medical conditions such as obesity, vascular disease, and renal disorders are also expected to drive the market during the forecast period. Moreover, bone growth stimulation products offer more benefits compared to traditional surgical therapies such as cost-effective and safe alternative mode to treat orthopedic diseases and bone fracture treatment. However, stringent approval process and limited medical reimbursement policies for bone stimulation products are expected to hinder the growth of the market.
The bone growth stimulators market is segmented into product, application, distribution channel, and region. By product, it is categorized into bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma. Depending on application, it is classified into spinal fusion surgeries, delayed union & nonunion bone fractures, oral & maxillofacial surgeries, and others. By distribution channel, it is divided into hospitals & clinics, home care, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global bone growth stimulators market along with the current trends and future estimations to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2018 to 2026 is provided to enable the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps to understand the application and products of bone growth stimulators used across the globe.
• Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Product
• Bone Growth Stimulation Devices
• Bone Morphogenetic Proteins
• Platelet-Rich Plasma
By Application
• Spinal Fusion Surgeries
• Delayed Union & Nonunion Bone Fractures
• Oral & Maxillofacial Surgeries
• Others
By Distribution Channel
• Hospitals & Clinics
• Home Care
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Arthrex, Inc.
• Essex Woodlands Healthcare Partners (Bioventus LLC)
• Colfax Corporation (DJO Global, Inc)
• Isto Biologics
• Johnson & Johnson (Depuy Synthes)
• Medtronic PLC
• Orthofix Medical Inc.
• Stryker Corporation
• Terumo Corporation
• Zimmer Biomet Holdings, Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
• ITO Physiotherapy & Rehabilitation
• Orchid Medical
• Ossatec Benelux Ltd.
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Market player positioning, 2018
3.3. Porter’s five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in demand for noninvasive and safer surgical treatments
3.4.1.2. Increase in number of patients demanding bone growth stimulators
3.4.1.3. Increase in government expenditure on healthcare
3.4.2. Restraint
3.4.2.1. Stringent approval process of bone growth stimulators
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.4. Impact analysis
CHAPTER 4: BONE GROWTH STIMULATORS TREATMENT MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Bone growth stimulation devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Bone Morphogenetic Proteins
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Platelet-rich plasma
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: BONE GROWTH STIMULATORS TREATMENT MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Spinal Fusion Surgeries
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Delayed Union & Nonunion Bone Fractures
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Oral & Maxillofacial Surgeries
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: BONE GROWTH STIMULATORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Home Care
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: BONE GROWTH STIMULATORS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. bone growth stimulators market, by product
7.2.2.1.2. U.S. bone growth stimulators market, by application
7.2.2.1.3. U.S. bone growth stimulators market, by distribution channel
7.2.2.2. Canada
7.2.2.2.1. Canada bone growth stimulators market, by product
7.2.2.2.2. Canada bone growth stimulators market, by application
7.2.2.2.3. Canada bone growth stimulators market, by distribution channel
7.2.2.3. Mexico
7.2.2.3.1. Mexico bone growth stimulators market, by product
7.2.2.3.2. Mexico bone growth stimulators market, by application
7.2.2.3.3. Mexico bone growth stimulators market, by distribution channel
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by distribution channel
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany bone growth stimulators market, by product
7.3.2.1.2. Germany bone growth stimulators market, by application
7.3.2.1.3. Germany bone growth stimulators market, by distribution channel
7.3.2.2. France
7.3.2.2.1. France bone growth stimulators market, by product
7.3.2.2.2. France bone growth stimulators market, by application
7.3.2.2.3. France bone growth stimulators market, by distribution channel
7.3.2.3. UK
7.3.2.3.1. UK bone growth stimulators market, by product
7.3.2.3.2. UK bone growth stimulators market, by application
7.3.2.3.3. UK bone growth stimulators market, by distribution channel
7.3.2.4. Italy
7.3.2.4.1. Italy bone growth stimulators market, by product
7.3.2.4.2. Italy bone growth stimulators market, by application
7.3.2.4.3. Italy bone growth stimulators market, by distribution channel
7.3.2.5. Spain
7.3.2.5.1. Spain bone growth stimulators market, by product
7.3.2.5.2. Spain bone growth stimulators market, by application
7.3.2.5.3. Spain bone growth stimulators market, by distribution channel
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe bone growth stimulators market, by product
7.3.2.6.2. Rest of Europe bone growth stimulators market, by application
7.3.2.6.3. Rest of Europe bone growth stimulators market, by distribution channel
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by distribution channel
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan bone growth stimulators market, by product
7.4.2.1.2. Japan bone growth stimulators market, by application
7.4.2.1.3. Japan bone growth stimulators market, by distribution channel
7.4.2.2. China
7.4.2.2.1. China bone growth stimulators market, by product
7.4.2.2.2. China bone growth stimulators market, by application
7.4.2.2.3. China bone growth stimulators market, by distribution channel
7.4.2.3. Australia
7.4.2.3.1. Australia bone growth stimulators market, by product
7.4.2.3.2. Australia bone growth stimulators market, by application
7.4.2.3.3. Australia bone growth stimulators market, by distribution channel
7.4.2.4. India
7.4.2.4.1. India bone growth stimulators market, by product
7.4.2.4.2. India bone growth stimulators market, by application
7.4.2.4.3. India bone growth stimulators market, by distribution channel
7.4.2.5. South Korea
7.4.2.5.1. South Korea bone growth stimulators market, by product
7.4.2.5.2. South Korea bone growth stimulators market, by application
7.4.2.5.3. South Korea bone growth stimulators market, by distribution channel
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific bone growth stimulators market, by product
7.4.2.6.2. Rest of Asia-Pacific bone growth stimulators market, by application
7.4.2.6.3. Rest of Asia-Pacific bone growth stimulators market, by distribution channel
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by distribution channel
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil bone growth stimulators market, by product
7.5.2.1.2. Brazil bone growth stimulators market, by application
7.5.2.1.3. Brazil bone growth stimulators market, by distribution channel
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia bone growth stimulators market, by product
7.5.2.2.2. Saudi Arabia bone growth stimulators market, by application
7.5.2.2.3. Saudi Arabia bone growth stimulators market, by distribution channel
7.5.2.3. South Africa
7.5.2.3.1. South Africa bone growth stimulators market, by product
7.5.2.3.2. South Africa bone growth stimulators market, by application
7.5.2.3.3. South Africa bone growth stimulators market, by distribution channel
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA bone growth stimulators market, by product
7.5.2.4.2. Rest of LAMEA bone growth stimulators market, by application
7.5.2.4.3. Rest of LAMEA bone growth stimulators market, by distribution channel
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by distribution channel
CHAPTER 8: COMPANY PROFILES
8.1. Arthrex, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.2. Essex Woodlands Healthcare Partners (Bioventus LLC)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.1. Key strategic moves and developments
8.3. Colfax Corporation (DJO Global, Inc)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Isto Biologics
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. JOHNSON & JOHNSON (DEPUY SYNTHES)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. MEDTRONIC PLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Orthofix Medical Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. STRYKER CORPORATION
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Terumo Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. ZIMMER BIOMET HOLDINGS, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
TABLE 01. GLOBAL BONE GROWTH STIMULATORS TREATMENT MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. BONE GROWTH STIMULATION DEVICES BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03. BONE MORPHOGENETIC PROTEINS BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. PLATELET-RICH PLASMA BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 05. GLOBAL BONE GROWTH STIMULATORS TREATMENT MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 06. SPINAL FUSION SURGERIES BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 07. DELAYED UNION & NONUNION BONE FRACTURES BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 08. ORAL AND MAXILLOFACIAL SURGERIES BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. OTHERS BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 10. GLOBAL BONE GROWTH STIMULATORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018–2026 ($MILLION)
TABLE 11. HOSPITALS & CLINICS BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 12. HOME CARE BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 13. OTHERS BONE GROWTH STIMULATORS TREATMENT MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 14. BONE GROWTH STIMULATORS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 15. NORTH AMERICA BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 16. U.S. BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 17. U.S. BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 18. U.S. BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 19. CANADA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 20. CANADA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 21. CANADA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 22. MEXICO BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 23. MEXICO BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 24. MEXICO BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 25. NORTH AMERICA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 26. NORTH AMERICA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 27. NORTH AMERICA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 28. EUROPE BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 29. GERMANY BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 30. GERMANY BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 31. GERMANY BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 32. FRANCE BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 33. FRANCE BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 34. FRANCE BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 35. UK BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 36. UK BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 37. UK BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 38. ITALY BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 39. ITALY BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 40. ITALY BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 41. SPAIN BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 42. SPAIN BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 43. SPAIN BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 44. REST OF EUROPE BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 45. REST OF EUROPE BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 46. REST OF EUROPE BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 47. EUROPE BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 48. EUROPE BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 49. EUROPE BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 50. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 51. JAPAN BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 52. JAPAN BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 53. JAPAN BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 54. CHINA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 55. CHINA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 56. CHINA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 57. AUSTRALIA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 58. AUSTRALIA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 59. AUSTRALIA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 60. INDIA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 61. INDIA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 62. INDIA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 63. SOUTH KOREA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 64. SOUTH KOREA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 65. SOUTH KOREA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 66. REST OF ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 67. REST OF ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 68. REST OF ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 69. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 70. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 71. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 72. LAMEA BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 73. BRAZIL BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 74. BRAZIL BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 75. BRAZIL BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 76. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 77. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 78. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 79. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 80. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 81. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 82. REST OF LAMEA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 83. REST OF LAMEA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 84. REST OF LAMEA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 85. LAMEA BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2018–2026
TABLE 86. LAMEA BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2018–2026
TABLE 87. LAMEA BONE GROWTH STIMULATORS MARKET, BY DISTRIBUTION CHANNEL, 2018–2026
TABLE 88. ARTHREX: COMPANY SNAPSHOT
TABLE 89. ARTHREX: PRODUCT PORTFOLIO
TABLE 90. EW HEALTHCARE: COMPANY SNAPSHOT
TABLE 91. EW HEALTHCARE: PRODUCT PORTFOLIO
TABLE 92. COLFAX: COMPANY SNAPSHOT
TABLE 93. COLFAX: OPERATING SEGMENTS
TABLE 94. COLFAX: PRODUCT PORTFOLIO
TABLE 95. ISTO: COMPANY SNAPSHOT
TABLE 96. ISTO: PRODUCT PORTFOLIO
TABLE 97. J&J: COMPANY SNAPSHOT
TABLE 98. J&J: OPERATING SEGMENTS
TABLE 99. J&J: PRODUCT TYPE PORTFOLIO
TABLE 100. MEDTRONIC: COMPANY SNAPSHOT
TABLE 101. MEDTRONIC: OPERATING SEGMENTS
TABLE 102. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 103. ORTHOFIX: COMPANY SNAPSHOT
TABLE 104. ORTHOFIX: OPERATING SEGMENTS
TABLE 105. ORTHOFIX: PRODUCT PORTFOLIO
TABLE 106. STRYKER: COMPANY SNAPSHOT
TABLE 107. STRYKER: OPERATING SEGMENTS
TABLE 108. STRYKER: PRODUCT PORTFOLIO
TABLE 109. TERUMO: COMPANY SNAPSHOT
TABLE 110. TERUMO: OPERATING SEGMENTS
TABLE 111. TERUMO: PRODUCT PORTFOLIO
TABLE 112. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 113. ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 114. ZIMMER BIOMET: PRODUCT PORTFOLIO
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
